Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study

BACKGROUND: Psychosis is rare in untreated patients with Parkinson's disease (PD) but the prevalence rises to 40% during dopaminergic treatment. So far, no systematic comparison of the psychogenic potential of different dopaminergic drugs had been performed. METHODS: Eighty PD patients with psy...

Descripción completa

Detalles Bibliográficos
Autores principales: Ecker, Daniel, Unrath, Alexander, Kassubek, Jan, Sabolek, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704166/
https://www.ncbi.nlm.nih.gov/pubmed/19515253
http://dx.doi.org/10.1186/1471-2377-9-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704166/
https://www.ncbi.nlm.nih.gov/pubmed/19515253
http://dx.doi.org/10.1186/1471-2377-9-23

Ejemplares similares